Astrana Health, Inc. (NASDAQ:ASTH) Short Interest Up 25.3% in December

Astrana Health, Inc. (NASDAQ:ASTH) was the target of a significant increase in short interest in December. As of December 15th, there was short interest totaling 2,982,920 shares, an increase of 25.3% from the November 30th total of 2,380,737 shares. Currently, 5.8% of the company’s stock are short sold. Based on an average trading volume of 494,597 shares, the days-to-cover ratio is currently 6.0 days. Based on an average trading volume of 494,597 shares, the days-to-cover ratio is currently 6.0 days. Currently, 5.8% of the company’s stock are short sold.

Astrana Health Price Performance

ASTH opened at $24.97 on Wednesday. The company has a quick ratio of 1.40, a current ratio of 1.40 and a debt-to-equity ratio of 1.27. Astrana Health has a twelve month low of $20.12 and a twelve month high of $39.97. The company has a market capitalization of $1.41 billion, a price-to-earnings ratio of 131.43, a PEG ratio of 1.53 and a beta of 0.86. The firm has a 50-day moving average price of $25.39 and a 200-day moving average price of $26.68.

Astrana Health (NASDAQ:ASTH) last released its quarterly earnings results on Wednesday, January 10th. The company reported $0.50 EPS for the quarter. Astrana Health had a net margin of 0.33% and a return on equity of 1.26%. The firm had revenue of $317.00 million during the quarter. Equities analysts expect that Astrana Health will post 1.15 EPS for the current year.

Analysts Set New Price Targets

Several research analysts have issued reports on the company. Weiss Ratings reissued a “sell (d+)” rating on shares of Astrana Health in a research note on Monday. Zacks Research cut Astrana Health from a “hold” rating to a “strong sell” rating in a report on Monday, November 10th. Needham & Company LLC started coverage on shares of Astrana Health in a research report on Friday, December 12th. They issued a “buy” rating and a $28.00 price target for the company. BTIG Research lowered their price objective on shares of Astrana Health from $50.00 to $45.00 and set a “buy” rating on the stock in a report on Friday, November 7th. Finally, Barclays dropped their price objective on shares of Astrana Health from $36.00 to $26.00 and set an “equal weight” rating on the stock in a research note on Monday, November 24th. Eight investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $41.33.

Institutional Investors Weigh In On Astrana Health

A number of institutional investors have recently made changes to their positions in the business. Covestor Ltd boosted its stake in shares of Astrana Health by 210.6% during the third quarter. Covestor Ltd now owns 3,233 shares of the company’s stock valued at $92,000 after purchasing an additional 2,192 shares during the period. Tower Research Capital LLC TRC grew its holdings in Astrana Health by 323.3% in the 2nd quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock worth $115,000 after acquiring an additional 3,517 shares during the last quarter. State of Wyoming purchased a new position in shares of Astrana Health in the second quarter valued at about $132,000. Hsbc Holdings PLC purchased a new stake in Astrana Health in the 1st quarter worth approximately $200,000. Finally, Citizens Financial Group Inc. RI purchased a new position in shares of Astrana Health during the third quarter valued at approximately $204,000. Hedge funds and other institutional investors own 52.77% of the company’s stock.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.